Tennessee · 114 session

SB 421 changesOpioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Precomputed change summary for the public. Sign in for the Diff Viewer (word-level redline, evidence, annotations, and exports).

Change log

Structural diff is ready; section summaries are not published yet. Sign in for the interactive Diff Viewer.

Word-level redline mode, annotations, and exports require a signed-in workspace. Track this bill.